Search

5 Oct 2011: Dr Jon Simons from the University of Cambridge’s Department of Experimental Psychology and Behavioural and Clinical Neuroscience Institute, who led the research. ... Dr Jon Simons from the University of Cambridge’s Department of Experimental

7 Mar 2011: It is free of charge and open to all. Given by Martin Johnson, Professor of Reproductive Sciences at the Department of Physiology, Development and Neuroscience and titled “Bob Edwards: the Early ... Bored by the course, he did badly and left with a

17 Mar 2011: The fact that drugs can produce mind-altering effects through chemical activity has been known for centuries,” explained Professor Robbins, who is Director of the Behavioural and Clinical Neuroscience Institute and ... Recent research by Professor

10 Aug 2011: author Professor Magdalena Zernicka-Goetz of The Wellcome Trust/Cancer Research UK Gurdon Institute and the Department of Physiology, Development and Neuroscience at Cambridge University. ... This saves prospective parents both the trauma and cost of the

4 Jan 2011: Professor Barry Everitt and Dr Jonathan Lee of the MRC-Wellcome Behaviour and Clinical Neuroscience Institute have shown that they can selectively impair memories associated with drug addiction and PTSD by ... memory reconsolidation and thereby drugs

22 Dec 2011: Lhotse, Nupste, and the mother goddess of the world herself, Sagarmatha - Mount Everest. ... Dr Andrew Murray. Andrew is a Lecturer in the Department of Physiology, Development and Neuroscience and a Fellow of Trinity Hall.

21 Oct 2011: All those photographed were from Cambridgeshire, participants in two longitudinal studies of ageing co-ordinated by Cambridge University’s Department of Public Health and Primary Care - the Cambridge City over-75s ... Enter your email address, confirm

6 May 2011: Scientific Visualisation: Dr. Petra Vertesand Naaman Tammuz on behalf of Cambridge Neuroscience and the Brain Mapping Unit, Department of Psychiatry. ... Presenter: Professor Ed Bullmore, Department of Psychiatry, Brain Mapping Unit, Behavioural Clinical

21 Oct 2011: models and published in Nature Neuroscience in January 2011. ... An effective treatment for halting the destruction of oligodendrocytes, alemtuzumab (Campath), was developed in Cambridge by Professor Alastair Compston and Dr Alasdair Coles at the

7 Sep 2011: The test will allow GPs to triage patients presenting memory problems quickly, simply and accurately. ... Enter your email address, confirm you're happy to receive our emails and then select 'Subscribe'.